Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease.
about
Progress and problems in understanding and managing primary Epstein-Barr virus infectionsT lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE)Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infectionAntibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaquesHow we treat chronic active Epstein-Barr virus infection.The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.A case of severe chronic active Epstein-Barr virus infection with T-cell lymphoproliferative disorder.An elderly patient with chronic active Epstein-Barr virus infection with mixed cryoglobulinemia and review of the literature.Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome.Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.EBV Chronic InfectionsExpression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease.Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line.CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNAClinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation.Immunologic difference between hypersensitivity to mosquito bite and hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infectionPhosphorylation of Epstein-Barr virus ZEBRA protein at its casein kinase 2 sites mediates its ability to repress activation of a viral lytic cycle late gene by Rta.Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferationsSignificance of the detection of Epstein-Barr virus DNA in lymph nodes in patients with Hodgkin's disease.Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein.Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction studyA survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas.Infection of human thymocytes by Epstein-Barr virus.Severe chronic active Epstein-Barr virus infection syndromeFulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy.The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent.The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner.Systemic EBV+ T-cell lymphoma in elderly patients: comparison with children and young adult patients.Early diagnosis and follow-up of chronic active Epstein-Barr-virus-associated cardiovascular complications with cardiovascular magnetic resonance imaging: A case reportReproduction of epstein-barr virus infection and pathogenesis in humanized mice.Oligonucleotide microarray analysis of gene expression profiles followed by real-time reverse-transcriptase polymerase chain reaction assay in chronic active Epstein-Barr virus infection.Epstein-Barr virus: more than 50 years old and still providing surprises.Isolation of Epstein-Barr virus-infected clones of the human T-cell line MT-2: use of recombinant viruses with a positive selection marker.Unusual Indolent Course of a Chronic Active Epstein-Barr Virus-Associated Natural Killer Cell Lymphoproliferative Disorder.Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection.Fatal non-transplant-related epstein-barr virus-associated atypical lymphoid proliferations in infants and children: a clinicopathologic study.Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.Presence of natural killer-cell clones with variable proliferative capacity in chronic active Epstein-Barr virus infection.Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.The ecology and pathology of Epstein-Barr virus.
P2860
Q24597706-A667D457-8346-4743-AEC2-7B43494B752BQ24672100-87FD2C5F-9B95-4206-83BF-0CB16D0A2795Q24684237-BC468989-E3D1-48F1-B72C-0130BC0E85F2Q27486549-E94B2A39-CA6C-4A90-8D93-7AD6AB1F7CFDQ30235902-378B88F8-1C9F-4A86-8974-08294AA94FB9Q30278553-108A3B7E-3867-4007-A7B9-4BFCE475F255Q33362585-A3198118-928D-463D-98BA-CCD70B2ED8C0Q33402839-977C393E-6689-4D94-BBB9-003B3BBF1274Q33902605-C10DA88B-7A33-4DB9-BBF6-8B5007067748Q34058148-F089B7FD-0FC8-4595-AF67-64B20A783E94Q34171625-3DE916FB-65D1-425D-B8D5-938ABF29DA4EQ34207259-B36D3712-8BD9-4C24-A0AC-6C839B313196Q34502958-4B9C0E27-A7DD-4DFB-9347-6DD8D7F7176DQ34576305-42925D73-3F3F-4B80-887A-5D8EDF416D1CQ34770812-F1F1F779-8368-483E-8A5E-E9F12C044EB3Q35034767-C0E78DE8-68A6-4990-B899-27DFE2FF5222Q35122852-14C52324-DC02-41BD-8538-C5286A6B498BQ35232848-9118A0D9-5443-4CE5-95A5-D87CBCAB9515Q35239264-71E36ECE-6271-46E2-B63D-373A05A4E7B6Q35764932-5A699144-66D3-4412-B495-43768C2A51E7Q35831567-B814ACB9-47F1-453B-A5A2-9920DB82CE6AQ35831803-B9642CA3-BC17-419B-9D0F-1A6B797FF9FCQ36360915-07FBCFE5-E67C-412D-B03F-4CDD1A5A607CQ36636997-97E31433-2EBE-49AD-A238-C3D8DE7D5A3FQ36784912-F2F3CC00-7AAF-4905-9765-BC7D97748AA5Q36804236-FE5C27E0-AA18-42CE-9168-3F61A8B62919Q36812174-B2FE934D-AAAA-4DBC-B0E3-5330633245D4Q36837619-F805E6CD-C5D9-44F2-927C-FC3477DBA43AQ37165033-5FAB6B3B-3CB7-43C0-80AD-28014C20A818Q37617205-C5E5A430-33AE-4070-AA53-E1BCEBBFD744Q38293702-7EAD901E-15EE-4250-8FEC-7DF613ED804DQ38968588-23133746-10FF-430E-8872-AA0D4FA3C610Q39870487-8F2507E2-75AA-4776-94D7-5F021CD6F955Q40104117-C2D2ECE1-ADE1-46C1-8912-27E2B08D5779Q40257591-8CEC30E7-5C2E-4576-86E5-F51DB5AF0D24Q40419375-8443DA8D-D742-4CD3-9CBF-F88D214C685CQ40582918-CFF595EF-9ED2-4938-84F6-7DC21D9D683DQ40746520-22504372-07AF-4B42-99C6-B0B875F97F2FQ40804641-278BE217-79D8-40EE-A24E-BA2B79783FE4Q41036904-570799E2-4B37-4C8E-A031-EE9DFEE835FD
P2860
Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Epstein-Barr virus genome-posi ...... ed with Kawasaki-like disease.
@en
type
label
Epstein-Barr virus genome-posi ...... ed with Kawasaki-like disease.
@en
prefLabel
Epstein-Barr virus genome-posi ...... ed with Kawasaki-like disease.
@en
P2093
P356
P1433
P1476
Epstein-Barr virus genome-posi ...... ed with Kawasaki-like disease.
@en
P2093
Ishizaka A
Kawamura N
Kinoshita T
Matsumoto S
Sakiyama Y
Tomizawa K
P2888
P304
P356
10.1038/333455A0
P407
P577
1988-06-01T00:00:00Z
P6179
1005165185